Charles Schwab Investment Management Inc Abeona Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 134,352 shares of ABEO stock, worth $646,233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,352
Previous 24,457
449.34%
Holding current value
$646,233
Previous $116,000
557.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABEO
# of Institutions
101Shares Held
31.4MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$21 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$14.8 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$12.9 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$12.1 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$10.1 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $28.6M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...